Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: Systematic review and meta-analysis of randomised controlled trials including more than 5000 women

Lancet Infectious Diseases

Volumn 2, Issue 10, 2002, Pages 613-617

  Wilkinson, David ^a   Tholandi, Maya ^b   Ramjee, Gita ^c   Rutherford, George W ^d  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONOXINOL 9; SPERMICIDAL AGENT;

CANDIDIASIS; CHLAMYDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME; TRICHOMONIASIS; UTERINE CERVICITIS; VAGINA; VAGINITIS;

EID: 0036787314     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(02)00396-1     Document Type: Review

References (26)

1. WHO. An overview of selected curable sexually transmitted diseases. Geneva: WHO, 1995.
2. UNAIDS. AIDS epidemic update: December 2000. Geneva: UNAIDS, 2000.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Trans Infect 1999; 75: 3-17.
4. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA 1991; 266: 1664-67.
5. Wilkinson D, Abdool Karim SS, Harrison A et al. Unrecognised sexually transmitted infections in rural South African women - the hidden epidemic. Bull World Health Organ 1999; 77: 22-28.
6. De Zoysa I, Sweat M, and Denison J. Faithful but fearful: reducing HIV transmission in stable relationships. AIDS 1996; 10(suppl): S197-203.
7. Elias C, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996; 10(suppl): S43-51.
8. Cook RL, Rosenberg MJ. Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? Sex Transm Dis 1998; 25: 144-50.
9. Roddy RE, Schulz KF, Cates W. Microbicides, metaanalysis, and the N-9 question. Sex Transm Dis 1998; 25: 151-53.
10. Kreiss J, Ngugi E, Holmes KK, et al. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992; 268: 477-82.
11. Rosenberg MJ, Rojanapithayakorn W, Feldblurn PJ, Higgins JE. Effect of the contraceptive sponge on chlamydial infection, gonorrhoea, and candidiasis. A comparative clinical trial. JAMA 1987; 257: 780-83.
12. Cutler JC, Singh B, Carpenter U, et al. Vaginal contraceptives as prophylaxis against gonorrhoea and other sexually transmissible diseases. Adv Planned Parenthood 1977; 12: 45-56.
13. Sacks SL, Varner TL, Davies KS, et al. Randomised, double-blind, placebo-controlled, patient initiated study of topical high- and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes. J Infect Dis 1990; 161: 692-98.
14. Roddy RE, Cordero M, Ryan KA, Figueroa J. A randomised controlled trial comparing nonoxynol-9 lubricated condoms with silicone lubricated condoms for prophylaxis. Sex Transm Infect 1997; 74: 116-19.
15. Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gyncol 1990; 163: 510-14.
16. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infection. J Infect Dis 1988; 158: 518-23.
17. Rendon AL, Covarrubias J, McCarney KE, Marion-Landais G, Luna del Villar J. A controlled comparative study of phenylmercuric acetate, nonoxynol-9 and placebo vaginal suppositories as prophylactic agents against gonorrhoea. Current Therapeutic Research 1980; 27: 780-83.
18. Niruthisard S, Roddy RE, Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992; 339: 1371-75.
19. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol-9 film to reduce male to female transmission of sexually transmitted diseases. N Engl J Med 1998; 339: 504-10.
20. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Tweedy KG. Nonoxynol-9 provides no prophylaxis for urogenital gonorrhoea and chlamydial infection: randomised controlled trial. JAMA 2002; 287: 1117-22.
21. Van Damme Lut, Ramjee G, Alary M, et al. Effectiveness on HIV-1 transmission of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. Lancet (in press).
22. Richardson BA, Lavreys L, Martin HL Jr, et al. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomised clinical trial. Sex Transm Dis 2001; 28: 394-400.
23. Benes S, McCormack WM. Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro, Antimicrob Agents Chemother 1985; 27: 724-6.
24. Malkovsky M, Newell A, Dalgleish AG. Inactivation of HIV by nonoxynol-9. Lancet 1988; 17: 645.
25. Miller CJ, Alexander NJ, Gettie A, Hendrickx AG, Marx PA. The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques. Fertil Steril 1992; 57: 1126-8.
26. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998; 316: 140-44.